https://www.fortunebusinessinsights.com/artificial-intelligence-in-drug-discovery-market-105354

Artificial Intelligence (AI) in Drug Discovery Market
for Personalized Medicine – 2030 Outlook
The artificial intelligence (AI) in drug discovery market focuses on using AI technologies to accelerate
and enhance the process of discovering new drugs. AI helps researchers identify potential drug candidates,
analyze complex biological data, and predict how compounds will interact with targets in the body. This
significantly reduces the time and cost traditionally involved in drug development. The market is rapidly
growing due to rising R&D costs, increasing demand for personalized medicine, and advancements in AI
algorithms. Pharmaceutical companies and biotech firms are increasingly partnering with AI companies to
improve drug discovery efficiency and success rates.
According to Fortune Business Insights, the global artificial intelligence (AI) in drug discovery market was
valued at USD 3.00 billion in 2022 and is projected to grow from USD 3.54 billion in 2023 to USD 7.94
billion by 2030, exhibiting a compound annual growth rate (CAGR) of 12.2% during the forecast period
(2023–2030). In 2022, North America dominated the market with a 69.33% share.